John T. Treace Buys $534K of Treace Medical Concepts Inc (TMCI) — SEC Form 4, Aug 24, 2022

Open-Market Net Purchase · SEC Form 4
+$533,756

Equity position changed by +0.3%

Reporting Owner
Officer 10% Owner
TXN 2022-08-24 · FILED 2022-08-24
Equity Position 10.8M sh 10,780,584 → 10,809,093
Equity Change +0.3% shares held after vs before
Filing Lag 0 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2022-08-24
Report Date
2022-08-23
Accession No.
0001209191-22-047407
Accepted At
2022-08-24 23:23 UTC
Reporting Owner
Name Relationship
John T. Treace CIK 0001856380
Director Officer 10% Owner
John T. Treace at Treace Medical Concepts Inc Full insider history
Bought (12 mo) $1,351,631
Sold (12 mo) —
More from this insider at Treace Medical Concepts Inc
2026-08-24 Buy +$246,654 View
2026-06-11 Buy +$210,968 View
2026-06-01 Buy +$177,915 View
2026-05-28 Buy +$340,589 View
2026-05-14 Buy +$375,505 View
All filings by this insider at Treace Medical Concepts Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2022-08-23 P - Purchase 28,000 A $18.72 +$524,124 5,484,455 Direct
Common StockF3F2 2022-08-24 P - Purchase 509 A $18.92 +$9,632 5,484,964 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common StockF4 1,605,000 Indirect
Common StockF4 1,471,250 Indirect
Common StockF5 1,839,063 Indirect
Common StockF5 408,816 Indirect
Footnotes (5)
F1
The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.28 to $19.01 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Show more
F2
Includes 33,875 restricted stock units. Show more
F3
The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.88 to $18.99 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Show more
F4
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
F5
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Treace Medical Concepts Inc
All Treace Medical Concepts Inc insider activity
GET /v1/forms/4/0001209191-22-047407 API docs
View Original SEC Filing